CellChorus
PrivateLast Round
Grant
Aug 25, 2025
Total Funding Raised
$599,000
Momentum Score
50 /100
Company Overview
CellChorus is a life sciences company that has developed a visual artificial intelligence platform for high-throughput, dynamic single-cell analysis. Its proprietary TIMING™ (Time-lapse Imaging Microscopy in Nanowell Grids) platform applies AI and neural networks to analyze microscopy videos, evaluating how individual cells move, interact, activate, kill, and survive over time. This technology provides researchers and biopharmaceutical companies with a deeper understanding of cellular function, state, and phenotype, enabling them to discover, develop, and manufacture novel cell therapies, antibodies, and vaccines more rapidly and with a higher probability of success. The company serves clients ranging from large biopharma companies to seed-stage biotechs. CellChorus is a spin-off from the University of Houston and has received backing from Y Combinator and multiple Small Business Innovation Research (SBIR) grants.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CellChorus Comps
Public and private peers based on sector, stage, and business model.
CellChorus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 25, 2025 | ||||
| Grant | May 2, 2024 | ||||
| Grant | Jun 28, 2023 | ||||
| Grant | Jun 21, 2023 | ||||
| Accelerator | Aug 31, 2021 |
CellChorus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Y Combinator | Accelerator |
| BioTools Innovator VANGUARD | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 25, 2025
$200K grant from BioTools Innovator VANGUARD.
CellChorus Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CellChorus's valuation, stock price, and market status.
